MEDICILON

contact us krjpencn

뉴스현황

Our Events

현재 위치: > 뉴스현황 > Our Events > Medicilon has been l...

Medicilon has been listed in the 2022 China Biopharmaceutical Innovation Billboard

저자:medicilon   업로드:2023-05-12  조회수:

On April 28, 2023, the China Biopharmaceutical Industry Chain Innovation Transformation Summit and the 3rd China Biopharmaceutical Innovation Billboard Awards Ceremony were grandly opened in Nanjing, China.

Shanghai Medicilon Inc (Medicilon) stands out among many CROs in the country by virtue of advanced R&D technology, innovative service platform, outstanding performance and excellent market reputation, as a result, Medicilon is awarded the “Golden Horse Award - 2022 Best Preclinical CRO/CDMO Enterprise.”

Medicilon

이전:최고 임시

다음에: Medicinal Chemistry in Small Nucleic Acid Drug Discovery